ClinicalTrials.gg
Sign In

Dermatitis, Contact clinical trials

The registry lists 61 studies for Dermatitis, Contact across more than 10 countries. 8 are recruiting or about to start. 39 of them are mainly about Dermatitis, Contact (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-16. Counting its 3 narrower conditions too, such as Dermatitis, Allergic Contact: 152 studies, 20 open.

Get an email when these change. Save the Dermatitis, Contact studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
45
Recruiting
6
Status unknown
5
Not yet recruiting
2
Active, not recruiting
1
Withdrawn
1

Phase

Phase 1
8
Phase 2
6
Phase 3
4
Phase 4
3

Where

United States
23
Denmark
12
Brazil
6
Israel
3
France
3
Canada
3

Who runs them

Allerderm (8) · Herbarium Laboratorio Botanico Ltda (6) · National Allergy Research Center, Denmark (4) · The University of Texas Health Science Center, Houston (2) · Hapten Sciences, Inc. (2) · Hadassah Medical Organization (2) · University of Split, School of Medicine (2) · University of Calgary (1)

What is being tested here

Drugs under test in Dermatitis, Contact studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mechlorethamine001
ATX201001
Omega-3 fatty acid001
Prednisolone acetate011
Prednisolone011
Glycerol001

Coming up

0phase 3 studies under way
1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Who these studies take

Of the 6 Dermatitis, Contact studies recruiting now, 3 (50%) set no upper age limit and 3 (50%) stop at 75 or younger. 3 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
103 (50%)3 (50%)
186 (100%)6 (100%)
305 (83%)5 (83%)
405 (83%)5 (83%)
505 (83%)5 (83%)
654 (67%)4 (67%)
753 (50%)3 (50%)
853 (50%)3 (50%)

Across all 61 studies, recruiting or not: 52% stop at 75 or younger and 38% at 65; 23% take children; 5% are for women only and 0% for men only; 48% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dermatitis, Contact studies take

Of 21 interventional studies with no phase under Dermatitis, Contact, half reached primary completion within 3 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase3 mo1–21 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 61. Browse all 61 → or search them.